Formulation

Oral solid dosage, HPAPIs, OSD development, OSD formulations, poorly soluble drugs, fixed-dose combinations, controlled release

The industry is under pressure to reduce the risks of nitrosamines in both in-development and on-market drug products.

Proprietary nanovesicles technology has caught the eye of Eli Lilly. We find out why.

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Maintaining the stability of vaccines over time and during temperature excursions is a crucial aspect of production, transport, and delivery.

New techniques in solid state chemistry are transforming the pharmaceutical landscape in drug formulation and delivery.

As 3D printing gains traction in the pharma industry, its potential to revolutionize solid oral dosage forms is becoming clearer.

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.